ISTHMUS PARTNERS, LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1639666 MADISON, WI

Position in HALO

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$506,876

+$120,971 QoQ

Shares Held

6,476

+8.5% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#389

of 666 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ISTHMUS PARTNERS, LLC holds $9,801,217 across 5 Biotechnology names. HALO ranks #4 (5.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	20,935	$6,617,344
2	MDXG	Mimedx Group, Inc.	530,709	$2,043,229
3	JAZZ	Jazz Pharmaceuticals plc	2,330	$561,460
4	HALO	Halozyme Therapeutics, Inc. This page	6,476	$506,876
5	OABI	OmniAb, Inc.	803,428	$72,308

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$506,876	6,476	+8.5%	Shares	Sole	2026-07-20
2026-03-31	$385,905	5,971	-11.2%	Shares	Sole	2026-04-30
2025-12-31	$452,457	6,723	-1.8%	Shares	Sole	2026-02-05
2025-09-30	$501,938	6,844	-0.5%	Shares	Sole	2025-11-10
2025-06-30	$357,637	6,875	0.0%	Shares	Sole	2025-08-13
2025-03-31	$438,693	6,875	+2.5%	Shares	Sole	2025-05-01
2024-12-31	$320,613	6,706	—	Shares	Sole	2025-02-07
No filing history on record for this holder in this stock.